A spectroscopic liquid biopsy with artificial intelligence for the early detection of cancer and other diseases.

A REVOLUTIONARY SPECTROSCOPIC LIQUID BIOPSY

Based on patented platform technology, the ClinSpec Dx™ spectroscopic liquid biopsy is a simple blood test able to discover disease early.

This low-cost technology has the potential to revolutionise the patient pathway; improving survival and quality-of-life to millions of patients worldwide.

And it's as simple and Drop, Dry, Detect™.

SHINING A LIGHT ON BRAIN TUMOURS

Brain tumours are difficult to detect, meaning that patients often recieve their diagnoses far too late. This patient pathway would greatly benefit from a liquid biopsy test that could help detect these patients earlier.

ClinSpec Dx™ aims to change the statistics that surround brain tumours.